0.00Open0.04Pre Close0 Volume399 Open Interest73.00Strike Price0.00Turnover1500.71%IV-1.75%PremiumNov 8, 2024Expiry Date1.34Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.0526Delta0.0589Gamma1858.50Leverage Ratio-85.0629Theta0.0000Rho97.78Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet